These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. High glutamic acid decarboxylase antibody titers may be associated with a decline in β-cell function over time and future insulin deficiency in latent autoimmune diabetes in adults. Haisa A, Oikawa Y, Satomura A, Suzuki S, Nakanishi S, Fujisawa M, Morita H, Katsuki T, Shimada A. Diabetes Res Clin Pract; 2024 Sep; 215():111799. PubMed ID: 39084295 [Abstract] [Full Text] [Related]
5. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults. Li X, Yang L, Zhou Z, Huang G, Yan X. Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146 [Abstract] [Full Text] [Related]
7. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function. Zhu Y, Qian L, Liu Q, Zou J, Zhou Y, Yang T, Huang G, Zhou Z, Liu Y. Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235 [Abstract] [Full Text] [Related]
11. High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults. Jin P, Huang G, Lin J, Yang L, Xiang B, Zhou W, Zhou Z. Clin Endocrinol (Oxf); 2011 May; 74(5):587-92. PubMed ID: 21470281 [Abstract] [Full Text] [Related]
17. GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial. Krause S, Landherr U, Agardh CD, Hausmann S, Link K, Hansen JM, Lynch KF, Powell M, Furmaniak J, Rees-Smith B, Bonifacio E, Ziegler AG, Lernmark A, Achenbach P. Diabetes Care; 2014 Jun; 37(6):1675-80. PubMed ID: 24598244 [Abstract] [Full Text] [Related]